Sorafenib tosylate
CAS:284461-73-0
Molecular Formula:C21H16ClF3N4O3
Molecular Weight:464.825 g/mol
Product description:Sorafenib tosylate is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advancedrenal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: